Tag: risk
Browse our exclusive articles!
US Tariffs: Only Sun Pharma exposed to some headline risk, but with limited earnings impact
The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not...
Indian pharma diversified but US exposure remains key risk: JPMorgan’s Bansi Desai
Speaking at JPMorgan’s 10th Annual India Conference, Bansi Desai, VP - India Healthcare & Pharma Research at JPMorgan, outlined how Indian pharmaceutical companies generate...
US tariffs pose major risk to India’s growth: Crisil Intelligence
High tariffs imposed by the United States on Indian goods pose a major risk to the country’s growth, Crisil Intelligence said in its September...
Axis Capital says H-1B risk is limited, prefers Infosys, Wipro, Mphasis, Hexaware
Manik Taneja, Executive Director for IT Services & Internet at Axis Capital, said Indian IT firms have steadily reduced their reliance on the H-1B...
